ATG4B and prostate cancer: In agreement with our results, over-expression of miR-34a reduces the expression of ATG4B, Beclin-1, and LC3B II/I in prostate cancer cells by downregulating p-AMPK and upregulating p-Mtor, an essential pathway related to cellular autophagy [54, 55].